Hendricks H.; et al. (2005). „Metabolism, mood and cognition in aging: the importance of lifestyle and dietary intervention“. Neurobiology of Aging. 26-jild. 1–5-bet. doi:10.1016/j.neurobiolaging.2005.10.005. PMID16290269.
Johnson, M.R.; Morris, NA; Astur, RS; Calhoun, VD; Mathalon, DH; Kiehl, KA; Pearlson, GD (2006). „A Functional Magnetic Resonance Imaging Study of Working Memory Abnormalities in Schizophrenia“. Biological Psychiatry. 60-jild, № 1. 11–21-bet. doi:10.1016/j.biopsych.2005.11.012. PMID16503328.
Whalley H.C.; et al. (2006). „Functional Imaging as a Predictor of Schizophrenia“. Biological Psychiatry. 60-jild, № 5. 454–62-bet. doi:10.1016/j.biopsych.2005.11.013. PMID16460690.
Pini S.; et al. (April–June 1999). „Detection and management of mental distress and psychiatric disorders in primary care settings“. Epidemiologia e Psichiatria Sociale. 8-jild, № 2. 92–104-bet. doi:10.1017/s1121189x00007594. PMID10540512.
Goldberg JF (May 2003). „When do antidepressants worsen the course of bipolar disorder?“. Journal of Psychiatric Practice. 9-jild, № 3. 181–94-bet. doi:10.1097/00131746-200305000-00002. PMID15985931.
Weitzner, M (1998). „Neuropsychiatry and pituitary disease: an overview“. Psychotherapy and Psychosomatics. 67-jild, № 3. 125–32-bet. doi:10.1159/000012272. PMID9667059.
Sonino N; Fava, GA (1998). „Psychosomatic aspects of Cushing's disease“. Psychotherapy and Psychosomatics. 67-jild, № 3. 140–6-bet. doi:10.1159/000012274. PMID9667061.
Larisch R; et al. (September 2004). „Depression and anxiety in different thyroid function states“. Hormone and Metabolic Research. 36-jild, № 9. 650–3-bet. doi:10.1055/s-2004-825925. PMID15486818.
Fink G; et al. (November 1999). „Androgen actions on central serotonin neurotransmission: relevance for mood, mental state and memory“. Behavioural Brain Research. 105-jild, № 1. 53–68-bet. doi:10.1016/S0166-4328(99)00082-0. PMID10553690.
López-Muñoz, Francisco; Alamo, Cecilio (2009). „Monoaminergic Neurotransmission: The History of the Discovery of Antidepressants from 1950s Until Today“. Current Pharmaceutical Design. 15-jild, № 14. 1565–1566-bet. doi:10.2174/138161209788168001. PMID19442174.
Ban, T.A. (2001). „Pharmacotherapy of depression: a historical analysis“. Journal of Neural Transmission. 108-jild, № 6. 707–16-bet. doi:10.1007/s007020170047. PMID11478422.
Ongür D.; et al. (2004). „A role for glia in the action of electroconvulsive therapy“. Harvard Review of Psychiatry. 12-jild, № 5. 253–62-bet. doi:10.1080/10673220490886185. PMID15590574.
Warner-Schmidt J.L.; et al. (2006). „Hippocampal neurogenesis: opposing effects of stress and antidepressant treatment“. Hippocampus. 16-jild, № 3. 239–49-bet. doi:10.1002/hipo.20156. PMID16425236.
Kodama M.; et al. (2004). „Chronic olanzapine or fluoxetine administration increases cell proliferation in hippocampus and prefrontal cortex of adult rat“. Biological Psychiatry. 56-jild, № 8. 570–80-bet. doi:10.1016/j.biopsych.2004.07.008. PMID15476686.
Duman, R.S. (2004). „Role of neurotrophic factors in the etiology and treatment of mood disorders“. Neuromolecular Medicine. 5-jild, № 1. 11–25-bet. doi:10.1385/NMM:5:1:011. PMID15001809.
Newton, S.S.; Duman, RS (2005). „Regulation of neurogenesis and angiogenesis in depression“. Curr Neurovasc Res. 1-jild, № 3. 261–7-bet. doi:10.2174/1567202043362388. PMID16181076.
McEwen, B. S. (September 2005). „Stressed or stressed out: what is the difference?“. Journal of Psychiatry and Neuroscience. 30-jild, № 5. 315–8-bet. PMC1197275. PMID16151535.
Hendricks H.; et al. (2005). „Metabolism, mood and cognition in aging: the importance of lifestyle and dietary intervention“. Neurobiology of Aging. 26-jild. 1–5-bet. doi:10.1016/j.neurobiolaging.2005.10.005. PMID16290269.
Johnson, M.R.; Morris, NA; Astur, RS; Calhoun, VD; Mathalon, DH; Kiehl, KA; Pearlson, GD (2006). „A Functional Magnetic Resonance Imaging Study of Working Memory Abnormalities in Schizophrenia“. Biological Psychiatry. 60-jild, № 1. 11–21-bet. doi:10.1016/j.biopsych.2005.11.012. PMID16503328.
Whalley H.C.; et al. (2006). „Functional Imaging as a Predictor of Schizophrenia“. Biological Psychiatry. 60-jild, № 5. 454–62-bet. doi:10.1016/j.biopsych.2005.11.013. PMID16460690.
Pini S.; et al. (April–June 1999). „Detection and management of mental distress and psychiatric disorders in primary care settings“. Epidemiologia e Psichiatria Sociale. 8-jild, № 2. 92–104-bet. doi:10.1017/s1121189x00007594. PMID10540512.
Goldberg JF (May 2003). „When do antidepressants worsen the course of bipolar disorder?“. Journal of Psychiatric Practice. 9-jild, № 3. 181–94-bet. doi:10.1097/00131746-200305000-00002. PMID15985931.
Weitzner, M (1998). „Neuropsychiatry and pituitary disease: an overview“. Psychotherapy and Psychosomatics. 67-jild, № 3. 125–32-bet. doi:10.1159/000012272. PMID9667059.
Sonino N; Fava, GA (1998). „Psychosomatic aspects of Cushing's disease“. Psychotherapy and Psychosomatics. 67-jild, № 3. 140–6-bet. doi:10.1159/000012274. PMID9667061.
Larisch R; et al. (September 2004). „Depression and anxiety in different thyroid function states“. Hormone and Metabolic Research. 36-jild, № 9. 650–3-bet. doi:10.1055/s-2004-825925. PMID15486818.
Fink G; et al. (November 1999). „Androgen actions on central serotonin neurotransmission: relevance for mood, mental state and memory“. Behavioural Brain Research. 105-jild, № 1. 53–68-bet. doi:10.1016/S0166-4328(99)00082-0. PMID10553690.
López-Muñoz, Francisco; Alamo, Cecilio (2009). „Monoaminergic Neurotransmission: The History of the Discovery of Antidepressants from 1950s Until Today“. Current Pharmaceutical Design. 15-jild, № 14. 1565–1566-bet. doi:10.2174/138161209788168001. PMID19442174.
Ban, T.A. (2001). „Pharmacotherapy of depression: a historical analysis“. Journal of Neural Transmission. 108-jild, № 6. 707–16-bet. doi:10.1007/s007020170047. PMID11478422.
Ongür D.; et al. (2004). „A role for glia in the action of electroconvulsive therapy“. Harvard Review of Psychiatry. 12-jild, № 5. 253–62-bet. doi:10.1080/10673220490886185. PMID15590574.
Warner-Schmidt J.L.; et al. (2006). „Hippocampal neurogenesis: opposing effects of stress and antidepressant treatment“. Hippocampus. 16-jild, № 3. 239–49-bet. doi:10.1002/hipo.20156. PMID16425236.
Kodama M.; et al. (2004). „Chronic olanzapine or fluoxetine administration increases cell proliferation in hippocampus and prefrontal cortex of adult rat“. Biological Psychiatry. 56-jild, № 8. 570–80-bet. doi:10.1016/j.biopsych.2004.07.008. PMID15476686.
Duman, R.S. (2004). „Role of neurotrophic factors in the etiology and treatment of mood disorders“. Neuromolecular Medicine. 5-jild, № 1. 11–25-bet. doi:10.1385/NMM:5:1:011. PMID15001809.
Newton, S.S.; Duman, RS (2005). „Regulation of neurogenesis and angiogenesis in depression“. Curr Neurovasc Res. 1-jild, № 3. 261–7-bet. doi:10.2174/1567202043362388. PMID16181076.
McEwen, B. S. (September 2005). „Stressed or stressed out: what is the difference?“. Journal of Psychiatry and Neuroscience. 30-jild, № 5. 315–8-bet. PMC1197275. PMID16151535.